RespireRx Pharmaceuticals Inc. (RSPI)
OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0003 (-16.67%)
At close: Oct 28, 2025
RespireRx Pharmaceuticals Statistics
Total Valuation
RSPI has a market cap or net worth of 1.71 million.
| Market Cap | 1.71M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Monday, November 17, 2025.
| Earnings Date | Nov 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RSPI has 949.46 million shares outstanding.
| Current Share Class | 949.46M |
| Shares Outstanding | 949.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +59.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,104.95% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 11.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.09M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.39% in the last 52 weeks. The beta is 0.37, so RSPI's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +15.39% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 80,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.41M |
| Pretax Income | -1.80M |
| Net Income | -2.17M |
| EBITDA | n/a |
| EBIT | -1.41M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 6,362 in cash and 2.78 million in debt, giving a net cash position of -2.77 million or -0.00 per share.
| Cash & Cash Equivalents | 6,362 |
| Total Debt | 2.78M |
| Net Cash | -2.77M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -12.30M |
| Book Value Per Share | -0.04 |
| Working Capital | -11.95M |
Cash Flow
| Operating Cash Flow | -247,570 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RSPI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.45% |
| Shareholder Yield | -63.45% |
| Earnings Yield | -127.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 2021. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 6, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |